1. Home
  2. LECO vs VTRS Comparison

LECO vs VTRS Comparison

Compare LECO & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln Electric Holdings Inc.

LECO

Lincoln Electric Holdings Inc.

N/A

Current Price

$241.93

Market Cap

12.5B

Sector

Industrials

ML Signal

N/A

Logo Viatris Inc.

VTRS

Viatris Inc.

N/A

Current Price

$11.69

Market Cap

12.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LECO
VTRS
Founded
1895
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
12.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LECO
VTRS
Price
$241.93
$11.69
Analyst Decision
Buy
Hold
Analyst Count
9
6
Target Price
$242.56
$11.50
AVG Volume (30 Days)
369.7K
7.4M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
1.30%
4.19%
EPS Growth
11.30
N/A
EPS
9.34
N/A
Revenue
$4,176,319,000.00
$14,124,400,000.00
Revenue This Year
$7.92
N/A
Revenue Next Year
$6.01
$1.16
P/E Ratio
$26.08
N/A
Revenue Growth
3.24
N/A
52 Week Low
$161.11
$6.85
52 Week High
$252.00
$12.78

Technical Indicators

Market Signals
Indicator
LECO
VTRS
Relative Strength Index (RSI) 55.37 69.15
Support Level $240.17 $10.67
Resistance Level $252.00 $11.83
Average True Range (ATR) 5.72 0.26
MACD 0.35 0.07
Stochastic Oscillator 50.59 88.31

Price Performance

Historical Comparison
LECO
VTRS

About LECO Lincoln Electric Holdings Inc.

Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. Its portfolio includes arc-welding solutions, plasma and oxy-fuel cutting systems, brazing and soldering alloys, and automation solutions. Lincoln Electric serves clients across general fabrication, heavy industries, automotive, construction, shipbuilding, energy, and process industries, among others. Based in Cleveland, Lincoln Electric operates in 19 countries and employs 11,000 worldwide. The company generated roughly $4 billion in sales in 2024.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: